KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to $841.0 million.

  • Lam Research's Operating Expenses rose 1378.2% to $841.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 1236.01%. This contributed to the annual value of $3.1 billion for FY2025, which is 1037.02% up from last year.
  • Lam Research's Operating Expenses amounted to $841.0 million in Q4 2025, which was up 1378.2% from $855.8 million recorded in Q3 2025.
  • In the past 5 years, Lam Research's Operating Expenses registered a high of $855.8 million during Q3 2025, and its lowest value of $584.8 million during Q1 2021.
  • For the 5-year period, Lam Research's Operating Expenses averaged around $692.0 million, with its median value being $679.8 million (2022).
  • In the last 5 years, Lam Research's Operating Expenses surged by 2366.92% in 2021 and then crashed by 283.9% in 2023.
  • Over the past 5 years, Lam Research's Operating Expenses (Quarter) stood at $639.8 million in 2021, then grew by 8.82% to $696.2 million in 2022, then rose by 0.58% to $700.2 million in 2023, then increased by 5.55% to $739.1 million in 2024, then increased by 13.78% to $841.0 million in 2025.
  • Its last three reported values are $841.0 million in Q4 2025, $855.8 million for Q3 2025, and $848.6 million during Q2 2025.